[HTML][HTML] Safety and efficacy of NVX-CoV2373 Covid-19 vaccine
…, G Glenn, J Rivers, A Robertson… - … England Journal of …, 2021 - Mass Medical Soc
Background Early clinical data from studies of the NVX-CoV2373 vaccine (Novavax), a
recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (…
recombinant nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2 (…
[HTML][HTML] Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine
C Keech, G Albert, I Cho, A Robertson… - New england journal …, 2020 - Mass Medical Soc
Background NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
[HTML][HTML] Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant
…, E Faust, JS Plested, A Robertson… - … England Journal of …, 2021 - Mass Medical Soc
Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a …
…, JS Plested, EJ Rivers, A Robertson… - The Lancet …, 2022 - thelancet.com
Background The safety and immunogenicity profile of COVID-19 vaccines when administered
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …
[HTML][HTML] Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo …
…, M Robinson, JS Plested, I Cho, A Robertson… - PLoS …, 2021 - journals.plos.org
Background NVX-CoV2373 is a recombinant severe acute respiratory coronavirus 2 (rSARS-CoV-2)
nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a …
…, B Zhou, G Chau, A Robertson… - The Lancet Infectious …, 2022 - thelancet.com
Background Emerging SARS-CoV-2 variants and evidence of waning vaccine efficacy
present substantial obstacles towards controlling the COVID-19 pandemic. Booster doses of …
present substantial obstacles towards controlling the COVID-19 pandemic. Booster doses of …
Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial
…, G Glenn, EJ Rivers, A Robertson… - Clinical Infectious …, 2023 - academic.oup.com
Background The recombinant protein-based vaccine, NVX-CoV2373, demonstrated 89.7%
efficacy against coronavirus disease 2019 (COVID-19) in a phase 3, randomized, observer-…
efficacy against coronavirus disease 2019 (COVID-19) in a phase 3, randomized, observer-…
[HTML][HTML] Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised …
…, G Albert, E Faust, JS Plested, L Fries, A Robertson… - The Lancet …, 2022 - thelancet.com
Background There is a paucity of data on COVID-19 vaccines in people living with HIV-1,
who could be at increased risk of severe illness and death from COVID-19. We evaluated the …
who could be at increased risk of severe illness and death from COVID-19. We evaluated the …
Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States)
ML McCullough, AS Robertson, C Rodriguez… - Cancer Causes & …, 2003 - Springer
Objective: Calcium, vitamin D, and dairy product intake may reduce the risk of colorectal
cancer. We therefore examined the association between these factors and risk of colorectal …
cancer. We therefore examined the association between these factors and risk of colorectal …
Unmet dental care needs among children with special health care needs: implications for the medical home
C Lewis, AS Robertson, S Phelps - Pediatrics, 2005 - publications.aap.org
Background. Little is known about the characteristics of children with special health care
needs (CSHCN) who have unmet dental care needs. Objective. We sought to describe the …
needs (CSHCN) who have unmet dental care needs. Objective. We sought to describe the …